Positive SNG001 Phase II Asthma Clinical Trial Data – Science 2.0 (press release)


Daily Mail

Positive SNG001 Phase II Asthma Clinical Trial Data
Science 2.0 (press release)
This pioneering trial investigated the potential for SNG001 (inhaled interferon beta) to protect asthmatics from respiratory virus infections (principally the common cold) that can spread to the lung, which are a major cause of worsening asthma
Asthma drug 'protects sufferers from life-threatening symptoms caused by Daily Mail
Synairgen's 'breakthrough' asthma drug shines in Phase II trialPharma Times
New drug 'reduces asthma symptoms'The Press Association
HealthExpress –Active Quote
all 24 news articles »

View full post on asthma – Google News